Articles
Daily market commentary and analysis.
Dow Sinks 1,100 Points as Anthropic's Debut Fails to Calm AI Worries
The Dow fell 1,101 points on Thursday as AI stocks reversed and Anthropic gave back most of its opening pop. Here's what drove it and what to watch.
Nov 20, 2026
Bloom Energy (BE) Upgraded by BMO Even as the Price Target Gets Trimmed
BMO upgraded Bloom Energy to Outperform but cut its target to $230 from $260. Here's what changed, what could go wrong, and what to watch.
Nov 20, 2026
Take-Two (TTWO) Jumps as GTA VI Reviews Hit 99 and Wall Street Raises Forecasts
Take-Two jumped 6% as GTA VI hit a 99 on Metacritic and Wells Fargo lifted its sales forecast to 65 million copies. Here's the setup, the risks, and what to watch next.
Nov 20, 2026
Fed Minutes Point to More Hikes, and Waller Floats a Half-Point
October FOMC minutes show almost all officials expect more rate hikes and a couple are open to more than 25 bps in December. Here's what it means for stocks, rates and your portfolio.
Nov 19, 2026
UnitedHealth (UNH) Falls 10% as CMS Targets Medicare Advantage Audits
UnitedHealth fell 10.2% and Humana 13% after CMS proposed extending Medicare Advantage audit clawbacks to 2018. Here's what the CRUSH rule does, the legal pushback, and what UNH holders should watch.
Nov 19, 2026
Target (TGT) Beats, Raises Outlook as Turnaround Gains Real Traffic
Target's Q3 comps rose 5.6% on 5.0% traffic growth and the retailer raised full-year EPS guidance to $10.65-$11.40. Here's what drove the beat, the tariff-refund caveat, and what to watch into the holidays.
Nov 19, 2026
Medtronic (MDT) Upgraded to Overweight by Piper Sandler With $120 Target
Piper Sandler upgraded Medtronic to Overweight and lifted its target to $120 from $85, ahead of the company's Dec. 11 investor meeting. Here's the bull case, the valuation catch, and what to watch.
Nov 18, 2026
Walmart (WMT) Gets a $145 Stifel Buy Call Two Days Before Earnings
Stifel resumed Walmart at Buy with a $145 target just ahead of Thursday's report. Options are pricing a bigger-than-usual move, and the stock already trades at a premium. Here's the setup and the risks.
Nov 18, 2026
Nvidia (NVDA) Beats Q3, Guides to $130 Billion, Steadies AI Trade
Nvidia's first report since Jensen Huang's exit delivered $115.8B in revenue, a $130B Q4 guide and a higher 2028 outlook. Here's what the numbers show, the risks in the fine print, and what to watch next.
Nov 18, 2026
Snowflake (SNOW) Is Down 26%, but Evercore ISI Still Sees 51% Upside
Evercore ISI's Kirk Materne reiterated a Buy and $430 target on Snowflake, about 51% above the stock's $285 price. Here's the case, the margin risk, and the Dec. 2 earnings test.
Nov 17, 2026
Gold Slides to a One-Year Low as December Fed Hike Looks Locked In
Spot gold fell about 4.5% last week and sits near $3,870, its lowest in more than a year, as a stronger dollar, hot inflation data and a likely December Fed hike weigh on bullion.
Nov 17, 2026
Anthropic's $64 Billion IPO Prices Wednesday: What Retail Investors Should Know
Anthropic (ANT) is set to price the year's biggest AI listing Wednesday at $70-$78 a share, with orders reportedly six times the shares on offer. Here's what to know before you try to buy.
Nov 17, 2026
China's Economy Misses in October, and AI Exports Are Carrying Growth
China's retail sales, industrial output and investment all missed forecasts in October, while exports jumped 35.2% on AI demand. Here's why the data matters for the AI trade, commodities and your portfolio.
Nov 16, 2026
Morgan Stanley Goes Max Overweight Stocks, Targets S&P 500 at 8,700
Morgan Stanley moved to maximum overweight on global equities for 2027 and raised its end-2027 S&P 500 target to 8,700, betting the AI capex cycle stays intact. Here's what it means for your portfolio.
Nov 16, 2026
Summit Therapeutics (SMMT) Sinks After FDA Rejects Lung Cancer Drug Ivonescimab
The FDA declined to approve ivonescimab over the lack of a statistically significant overall survival benefit. Summit fell 14%-20% premarket and Akeso dropped as much as 32%. Here's what's still intact and what to watch.
Nov 16, 2026
Palo Alto Gets a KeyBanc Upgrade as a Microsoft Outage Lifts Cybersecurity Stocks
KeyBanc upgraded Palo Alto Networks to overweight with a $380 target as a Microsoft outage pushed buyers toward CrowdStrike and other independent security names.
Nov 13, 2026
Cisco Beats, Raises Guidance and Still Drops 6%: What the Market Is Pricing
Cisco posted its fastest growth in over 15 years and lifted its outlook, yet shares slid about 6% Friday as analysts zeroed in on softer hyperscaler AI orders.
Nov 13, 2026
Nvidia After Jensen Huang: HSBC Downgrades, Shares Slide on Succession Risk
Jensen Huang resigned as Nvidia CEO and HSBC cut the stock to hold, saying uncertainty will linger until a permanent successor is named.
Nov 13, 2026
Oil Slides Toward Two-Month Low as Gulf Output Surges Back
Brent is hovering near $91 as Saudi and Iraqi output climbs and US-Iran talks stall. Here's why the drop matters for inflation, energy stocks and your portfolio, and what could reverse it.
Nov 12, 2026
Microsoft (MSFT) Slips as Anthropic's Claude Sheets Goes After Excel
Microsoft fell more than 2% on Tuesday and slid again Wednesday after Anthropic launched Claude Sheets, Whiteboards and Data. Here's what's at stake in Microsoft 365 and what to watch.
Nov 12, 2026